Biomedical Catalyst 2022 Round 2: Industry-led R&D

UK registered SMEs can apply for a share of up to £25 million to develop innovative solutions to health and healthcare challenges.

Funding Details
When

Registration Opens

15/08/2022

Registration Closes

12/10/2022

Award

Your project’s total costs must be between £150,000 and £4 million. The total grant cannot exceed £2 million; this can cover up to 70% of costs depending on business size.

Organisation

Innovate UK

Share this opportunity

Innovate UK, part of UK Research and Innovation is to invest up to £25 million in projects to support UK registered businesses to develop innovative solutions to address significant health or healthcare challenges.

Your project can focus on:

  • disease prevention and proactive management of health and chronic conditions
  • earlier and better detection and diagnosis of disease, leading to better patient outcomes
  • tailored treatments that either change the underlying disease or offer potential cures
  • transforming the delivery of healthcare

This list is not intended to be exhaustive.

The Industry led research and development (R&D) stream of the Biomedical Catalyst programme supports pre-market R&D projects. Applicants must be able to demonstrate existing evidence of commercial and technical feasibility. Applications must show how they will improve the competitiveness and productivity of at least one UK SME involved in the project.

Your project must:

  • have total project costs between £150,000 and £4 million
  • not exceed a grant request of £2 million
  • have at least 50% of the total project costs shared by the SMEs, if collaborative
  • start by 1 May 2023
  • end by 30 April 2026
  • last between 6 months and 36 months
  • carry out all of its project work in the UK
  • intend to exploit the results from or in the UK

You must only include eligible project costs in your application. If you have requested an overall grant of over £500,000, and your online application is successful at Stage 1, you may be invited to attend an interview.

To lead a project or work alone your organisation must be a UK registered micro, small or medium-sized enterprise (SME).

An SME can only lead on one application but can be included as a collaborator in a further 2 applications. If an SME is not leading on any application, it can collaborate in any number of applications. An RTO, a large business, academic institution, charity, not for profit, or public sector organisation can collaborate on any number of applications.

Scope

The aim of this industry-led R&D competition is to support the development of innovative solutions to health and healthcare challenges.

We will only support innovation projects conducted to the highest standards of animal welfare. Further information is available at the UKRI Good Research Hub and NC3R’s animal welfare guidance .

Your project can include:

  • experimental evaluation (at laboratory scale)
  • use of in vitro and in vivo models to evaluate proof of concept or safety
  • exploring potential production mechanisms
  • prototyping
  • product development planning
  • intellectual property protection
  • a demonstration of clinical utility and effectiveness
  • a demonstration of safety and efficacy (including phase 1 and 2 clinical trials)
  • regulatory planning

Your project can focus on any health or healthcare sector or discipline. The Biomedical Catalyst now incorporates the Digital Health Technology Catalyst and will support digital health projects.

Your project can align with one or more of the following Innovation areas (list not exhaustive):

  • biosciences
  • advanced therapies (gene and cell therapies)
  • diagnostic, medical technology and devices
  • digital health
  • independent living and wellbeing
  • precision medicine
  • preclinical technologies and drug target discovery
  • therapeutic and medicine development
  • data driven health

An online briefing event will be held at 11.30am on 23rd August: click here for the joining link.